Open AccessThe cost-effectiveness of sequential versus standard triple therapy for Helicobacter pylori eradication in Saudi Arabia
Author(s) -
Yazed AlRuthia,
Majid A. Almadi,
Sadeem Alqahtani,
Hala Alrasheed,
Mohammad Al-Owairdhi,
Fahad Alsohaibani
Publication year - 2021
Publication title -
the saudi journal of gastroenterology/saudi journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.608
H-Index - 32
eISSN - 1998-4049
pISSN - 1319-3767
DOI - 10.4103/sjg.sjg_536_20
Subject(s) - esomeprazole , medicine , clarithromycin , helicobacter pylori , urea breath test , amoxicillin , tinidazole , regimen , randomized controlled trial , placebo , gastroenterology , antibiotics , metronidazole , helicobacter pylori infection , microbiology and biotechnology , alternative medicine , pathology , biology
The utilization rate of different treatment regimens for Helicobacter pylori infection is believed to be high; however, the cost-effectiveness of these regimens has not been examined before. Therefore, the aim of this study was to examine the cost-effectiveness of the two commonly prescribed treatments for H. pylori infection.